HealthEquity Inc header image

HealthEquity Inc

HQY

Equity

ISIN null / Valor 24679014

NASDAQ (2026-09-25)
USD 88.25-0.40%

HealthEquity Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

HealthEquity Inc is a prominent player in the healthcare and financial services industry, specializing in providing a range of solutions aimed at facilitating health savings and optimizing healthcare spending for individuals and employers. The company has significantly expanded its network and service offerings since its inception, growing from 10 to over 175 partnerships with health plans, record keepers, benefits administrators, brokers, and consultants. This expansion underscores HealthEquity's commitment to broadening its reach and enhancing its service capabilities. A key aspect of its business strategy has been the successful integration of WageWorks, a provider of tax-advantaged Consumer Directed Benefit (CDB) account administration, which has further solidified HealthEquity's position in the market. The company places a strong emphasis on technology and innovation, with efforts focused on security, unification, and simplification of its technology infrastructure to improve customer experience for its more than 14 million members. Through leveraging advanced technologies such as AI, cloud computing, open APIs, and development platforms, HealthEquity aims to digitally transform its business and scale its solutions to meet the evolving needs of its clients.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-8.23%1Y
19.8%3Y
33.5%5Y

Performance

35.7%1Y
36.6%3Y
40.8%5Y

Volatility

Market cap

7300 M

Market cap (USD)

Daily traded volume (Shares)

1,282,445

Daily traded volume (Shares)

1 day high/low

97.54 / 95.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.00
Matthew Mukesh
UK, 16 Nov 2025
star star star star star
Interesting my

EQUITIES OF THE SAME SECTOR

Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%USD 4.13
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%CHF 82.55
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.39%CHF 360.40
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.08%USD 36.15
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%CHF 86.20
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%USD 10.94
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.25%EUR 0.98
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 99.51
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 5.70
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.79%CHF 10.46